Pancreatic health monitoring after diabetes diagnosis
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study follows people newly diagnosed with type 2 diabetes to check their pancreas health using blood tests and MRI scans. It aims to find any early signs of pancreatic disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 84 years old
- You have been diagnosed with type 2 diabetes in the last 6 months
- You are willing to give blood samples (about 2 tablespoons) at each visit
- You are able to have an MRI scan (or CT scan if MRI is not safe for you)
- You have not had pancreatic cancer, a pancreatic tumor, or pancreatitis before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether regular imaging can find pancreatic cancer earlier in people who recently developed diabetes or whose diabetes is getting worse. It may help detect pancreatic problems sooner when treatment options are likely better.
This study takes pictures of the pancreas in children and teens (and likely adults) with type 1 diabetes soon after diagnosis. The goal is to learn more about how the pancreas changes with diabetes, which may help future care.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study looks at blood “markers” to find early signs or higher risk for pancreatic cancer. You may join if you have certain risk factors (like new diabetes, pancreatic cysts/pancreatitis, or a strong family history) and can come to Omaha for blood draws twice a year.
This study will see if people over 50 with new-onset diabetes can benefit from imaging scans (CT or endoscopic ultrasound) to help catch pancreatic ductal adenocarcinoma at an early stage. The goal is to screen those who might be at higher risk based on the END-PDAC score.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.